A Study to Compare PK, PD and Safety of UI058 and UIC202004 in Healthy Subjects

A Randomized, Open-label, Multiple-dose, Crossover Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics Between "UI058" and "UIC202004" in Healthy Subjects

A Study to compare pharmacokinetics, pharmacodynamics and safety of UI058 and UIC202004 in healthy subjects

Inclusion Criteria:

• Subjects able to read and understand a written informed consent, and willing to decide to participate in the study
• Healthy subjects between the ages of 19 and 55 years at screening
• Body weight more than 50.0kg(male)/45.0kg(female)
• Body Mass Index more than 18.0kg/m2 and under 30.0kg/m2

Exclusion Criteria:

• Have clinically significant disease that hepatobiliary system, kidney, respiratory system, nervous system, hemato-oncology disease, cardiovascular system
• Have a gastrointestinal disease history that can effect drug absorption or surgery
• Hypersensitivity reaction or clinically significant hypersensitivity reaction in the history of investigational product